Saba Capital Management, L.P. bought HQL
May 6, 2024 · Form 4 insider transaction
Saba Capital Management, L.P. bought 10,713 shares of Abrdn Life Sciences Investors at $13.62 per share, a transaction worth $145.9K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
10,713
Price
$13.62
Total value
$145.9K
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMay 6, 2024
Filing dateMay 7, 2024
Shares owned after3,079,443
OwnershipIndirect
10b5-1 planNo
AmendedNo